Free Trial

Ardent Health's (ARDT) "Outperform" Rating Reiterated at Leerink Partners

Ardent Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Ardent Health (NYSE:ARDT - Get Free Report)'s stock had its "outperform" rating reissued by Leerink Partners in a research report issued to clients and investors on Friday, September 18th, Benzinga reports. They currently have a $14.00 price target on the stock. Leerink Partners' price objective suggests a potential upside of 32.51% from the company's previous close.

A number of other analysts also recently issued reports on ARDT. Truist Financial lifted their price target on Ardent Health from $12.00 to $13.00 and gave the stock a "buy" rating in a report on Thursday, August 6th. Guggenheim lifted their price target on Ardent Health from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Thursday, August 6th. Weiss Ratings downgraded Ardent Health from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, August 11th. The Goldman Sachs Group reaffirmed a "neutral" rating and set a $13.00 price target on shares of Ardent Health in a report on Thursday, August 6th. Finally, Zacks Research raised Ardent Health from a "strong sell" rating to a "hold" rating in a report on Monday, September 7th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Ardent Health has an average rating of "Hold" and an average price target of $12.79.

Read Our Latest Research Report on ARDT

Ardent Health Stock Up 0.8%

NYSE:ARDT traded up $0.09 during midday trading on Friday, reaching $10.57. The company had a trading volume of 251,879 shares, compared to its average volume of 451,909. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of 19.21, a PEG ratio of 3.10 and a beta of 0.71. The stock's fifty day simple moving average is $10.86 and its 200-day simple moving average is $9.94. Ardent Health has a 12-month low of $7.71 and a 12-month high of $15.48. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61.

Ardent Health (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.06). The company had revenue of $1.62 billion during the quarter, compared to analysts' expectations of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, sell-side analysts anticipate that Ardent Health will post 0.96 earnings per share for the current fiscal year.

Institutional Trading of Ardent Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. The Manufacturers Life Insurance Company increased its position in Ardent Health by 3.7% in the 1st quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company's stock valued at $255,000 after acquiring an additional 1,072 shares during the period. Allworth Financial LP increased its position in Ardent Health by 131.3% in the 2nd quarter. Allworth Financial LP now owns 2,863 shares of the company's stock valued at $28,000 after acquiring an additional 1,625 shares during the period. Caitong International Asset Management Co. Ltd increased its position in Ardent Health by 2,036.6% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,786 shares of the company's stock valued at $42,000 after acquiring an additional 4,562 shares during the period. Integrated Wealth Concepts LLC acquired a new position in Ardent Health in the 2nd quarter valued at about $57,000. Finally, Monetary Solutions Ltd acquired a new position in Ardent Health in the 4th quarter valued at about $79,000.

About Ardent Health

(Get Free Report)

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.

See Also

Analyst Recommendations for Ardent Health (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Right Now?

Before you consider Ardent Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.

While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines